Epoetin alfa

Epoetin alfa
Klinički podaci
Prodajno ime	Epogen, Epogen (Amgen Inc.), Epogin (Chugai), Epomax (Elanex)
Drugs.com	alfa.html Monografija
Način primene	Subkutano, intravenozno
Identifikatori
CAS broj	113427-24-0^Y
ATC kod	B03XA02 (WHO), B03XA01
DrugBank	DB00016^Y
ChEMBL	CHEMBL1201565^Y
Hemijski podaci
Formula	C₈₁₅H₁₃₁₇N₂₃₃O₂₄₁S₅
Molarna masa	18396.1

Fizički podaci
Tačka topljenja	53 °C (127 °F)

Epoetin alfa (rINN) rekombinantni je ljudski eritropoietin, koji se proizvodi u CHO ćelijama.^[1]^[2]^[3]

Reference

^ Walsh G, Spada S (2005). „Epogen/Procrit”. Directory of approved biopharmaceutical products. Boca Raton: CRC Press. стр. 39–41. ISBN 978-0-415-26368-9.
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. уреди
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958. уреди

Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.